Raymond James Financial
VCYT icon

Raymond James Financial’s Veracyte VCYT Stock Holding History

Raymond James Financial’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Sell
370,261
-14,068
-4% -$521K ﹤0.01% 1910
2025
Q4 		$16.2M Buy
384,329
+187,334
+95% +$7.55M 0.01% 1585
2025
Q3 		$6.76M Sell
196,995
-8,333
-4% -$239K ﹤0.01% 2233
2025
Q2 		$5.55M Sell
205,328
-7,746
-4% -$224K ﹤0.01% 2308
2025
Q1 		$6.32M Buy
213,074
+172,010
+419% +$6.56M ﹤0.01% 2171
2024
Q4 		$1.63M Buy
+41,064
New +$1.55M ﹤0.01% 3116

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Raymond James Financial's VCYT Position: Q1 2026 in Review

Raymond James Financial reduced its Veracyte (VCYT) stake by 3.7% in Q1 2026, selling an estimated $521K and leaving 370,261 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Raymond James Financial first reported a position in VCYT in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.2M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Raymond James Financial held 370,261 shares of Veracyte worth $11.4M as of Q1 2026.
  • Raymond James Financial sold 14,068 Veracyte shares in Q1 2026, an estimated $521K.
  • Veracyte made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #1910 holding.
  • Raymond James Financial first reported a position in Veracyte in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Veracyte position peaked at $16.2M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.